Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Maffrand

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Thrombosis and Haemostasis|October 6, 1998
SR 121787, a new orally active fibrinogen receptor antagonistP Savi, A Badorc, A Lalé, et al.
Circulation Research|January 1, 1992
ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteriesS K Yao, J C Ober, J McNatt, et al.
Kidney International|September 21, 2007
Blockade of cannabinoid CB1 receptors improves renal function, metabolic profile, and increased survival of obese Zucker ratsP Janiak, B Poirier, J-P Bidouard, et al.
The Journal of Biological Chemistry|August 29, 1997
A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. Evidence for a new model of receptor/ligand interactionsM Bouaboula, S Perrachon, L Milligan, et al.
Fundamental & Clinical Pharmacology|January 1, 1996
The arterial wall: a new pharmacological and therapeutic targetS Laurent, P Vanhoutte, I Cavero, et al.
European Journal of Pharmacology|December 16, 1998
Neurotensin is an antagonist of the human neurotensin NT2 receptor expressed in Chinese hamster ovary cellsN Vita, F Oury-Donat, P Chalon, et al.
The Journal of Biological Chemistry|October 27, 1997
Purification and characterization of the human SR 31747A-binding protein. A nuclear membrane protein related to yeast sterol isomeraseO Jbilo, H Vidal, R Paul, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1997
Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonistD Gully, B Labeeuw, R Boigegrain, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 24, 1999
SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. II. In vivo pharmacological characterizationE Bignon, R Alonso, M Arnone, et al.
Neuropeptides|December 31, 1997
Biochemical and pharmacological activities of SR 144190, a new potent non-peptide tachykinin NK2 receptor antagonistX Emonds-Alt, C Advenier, C Cognon, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Thrombosis and Haemostasis|October 6, 1998
SR 121787, a new orally active fibrinogen receptor antagonistP Savi, A Badorc, A Lalé, et al.
Circulation Research|January 1, 1992
ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteriesS K Yao, J C Ober, J McNatt, et al.
Kidney International|September 21, 2007
Blockade of cannabinoid CB1 receptors improves renal function, metabolic profile, and increased survival of obese Zucker ratsP Janiak, B Poirier, J-P Bidouard, et al.
The Journal of Biological Chemistry|August 29, 1997
A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. Evidence for a new model of receptor/ligand interactionsM Bouaboula, S Perrachon, L Milligan, et al.
Fundamental & Clinical Pharmacology|January 1, 1996
The arterial wall: a new pharmacological and therapeutic targetS Laurent, P Vanhoutte, I Cavero, et al.
European Journal of Pharmacology|December 16, 1998
Neurotensin is an antagonist of the human neurotensin NT2 receptor expressed in Chinese hamster ovary cellsN Vita, F Oury-Donat, P Chalon, et al.
The Journal of Biological Chemistry|October 27, 1997
Purification and characterization of the human SR 31747A-binding protein. A nuclear membrane protein related to yeast sterol isomeraseO Jbilo, H Vidal, R Paul, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1997
Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonistD Gully, B Labeeuw, R Boigegrain, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 24, 1999
SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. II. In vivo pharmacological characterizationE Bignon, R Alonso, M Arnone, et al.
Neuropeptides|December 31, 1997
Biochemical and pharmacological activities of SR 144190, a new potent non-peptide tachykinin NK2 receptor antagonistX Emonds-Alt, C Advenier, C Cognon, et al.
Pageof 12